行情

ABBV

ABBV

艾伯维
NYSE

实时行情|Nasdaq Last Sale

75.39
-0.34
-0.45%
盘后: 75.12 -0.27 -0.36% 19:34 04/07 EDT
开盘
78.38
昨收
75.73
最高
78.58
最低
75.25
成交量
1,158.84万
成交额
--
52周最高
97.86
52周最低
62.55
市值
1,113.27亿
市盈率(TTM)
14.28
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ABBV价格均价为93.77,最高价位106.00,最低价为70.00。

EPS

ABBV 新闻

更多
  • Cramer's lightning round: 'Take a look at Boeing'
  • CNBC.com · 1小时前
  • AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know
  • Zacks · 1小时前
  • 5%+ Dividend Yield Portfolio: Buying When Things Go On Sale (Mar 2020 Review)
  • Seeking Alpha - Article · 4小时前
  • Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM
  • Zacks · 5小时前

所属板块

制药
-0.19%
制药与医学研究
-0.82%

热门股票

代码
价格
涨跌幅

ABBV 简况

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
展开

微牛提供AbbVie Inc(NYSE-ABBV)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ABBV股票新闻,以帮助您做出投资决策。